Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-24 @ 5:07 PM
NCT ID:
NCT02432950
Eligibility Criteria:
Inclusion Criteria:
* Patients with early-stage breast cancer (stage I-III)
* Patients who have or have not undergone chemotherapy are both eligible; if the patient has undergone chemotherapy she must have completed adjuvant chemotherapy for \>= 3 months and =\< 5 years prior to study enrollment
* Postmenopausal women defined by either: natural menopause with at least one year since last menses, or chemotherapy-induced menopause with at least one year since last menses and follicle-stimulating hormone (FSH) and estradiol levels within the postmenopausal range
* Body mass index (BMI) of 25-33 kg/m\^2
* Patients must be willing to adhere to the PNP intervention and the entire 6-month study
* All patients must have the ability and the willingness to sign a written informed consent
Exclusion Criteria:
* Patients who are diabetic
* Patients whose BMI falls outside the eligible range (\< 25 kg/m\^2 or \> 33 kg/m\^2)
* Patients with stage IV breast cancer
* Patients with Rheumatoid Arthritis and other inflammatory diseases that would impact correlative studies
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT02432950
Study Brief:
Protocol Section:
NCT02432950